Get started
Author

Marta Valero

Observed names: M. Valero, Marta Valero A
Observed institution: Hospital Arnau de Vilanova
ORCID: 0000-0003-4110-9507
Observed ORCID: 0000-0003-4110-9507
OpenAlex ID: A5101405884
Risk factors and outcome of COVID-19 in patients with hematological malignancies
2020 · José Luis Piñana, Rodrigo Martino, et al. · Experimental Hematology and Oncology · 158
PDF
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations
2015 · Aurelio Lopez, Maria-Victoria Mateos, et al. · Leukemia Research Reports · 17
PDF
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain
2023 · Anna Torrent, Mireia Morgades, et al. · European Journal Of Haematology · 6
PDF
S132: Updated Results of Ven-a-qui Study: a Phase 1-2 Trial to Assess the Safety and Efficacy of Triplets for Newly Diagnosed Unfit Aml Patients: Azacitidine or Low-dose Cytarabine With Venetoclax and Quizartinib
2023 · Juan Miguel Bergua Burgues, Rebeca Rodríguez-Veiga, et al. · HemaSphere · 5
Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression
2013 · Aurelio Lopez, Marta Valero, et al. · Blood · 2
A High Percentage of DNAM-1+ and Low Percentage of Tactile+ NK Cells at Diagnosis Correlate with Complete Response and Survival in AML: A Sub-Analysis of the Ven-a-Qui Pethema Trial
2023 · Juan Miguel Bergua Burgues, Raquel Tarazona, et al. · Blood · 1
PDF
Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study
2026 · Eva Barragán, José Vicente Gil, et al. · Blood Neoplasia
Results of the Compassionate Program of Inotuzumab Ozogamicin for Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia in Spain
2021 · Josep-Maria Ribera, Olga Garcia, et al. · Blood
Patterns of relapse and outcome of elderly multiple myeloma patients treated with VMP or VTP as induction followed by maintenance with VT or VP in the Spanish GEM2005MAS65 trial
2015 · A. López, M.-V. Mateos, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 10
Citation count: 189
H-index: 4
I10-index: 2
Year
Topic
Type